102P A Real-World Study Comparing Apatinib Combined with Irinotecan Versus Irinotecan As Second-Line or above Therapy in Patients with Advanced or Metastatic Gastric Cancer
Annals of Oncology(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Annals of Oncology(2022)